Rare diseases
Investigational molecules
Locations
Back to the Netherlands562 clinical trials in Groningen, The Netherlands across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors
The NetherlandsStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
The NetherlandsStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
The NetherlandsThe NetherlandsStudy on JDQ443 for Patients with KRAS G12C+ Non-Small Cell Lung Cancer and Brain Metastases
The NetherlandsStudy of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer
The NetherlandsStudy on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment
The NetherlandsStudy of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Patients with Newly Diagnosed AL Amyloidosis with Heart Involvement
The NetherlandsStudy on Nalbuphine ER for Treating Cough in Patients with Idiopathic Pulmonary Fibrosis
The NetherlandsStudy Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
The NetherlandsStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
The NetherlandsStudy of Brexucabtagene Autoleucel in Patients with Relapsed or Refractory Mantle Cell Lymphoma
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Advanced studies focusing on heart disease and cardiovascular conditions, including innovative treatments for ATTR amyloidosis and prevention strategies for heart failure.
Multiple trials exploring novel therapeutic approaches and preventive measures for various cardiac conditions.
Comprehensive research into various cancer types, including melanoma and lung cancer, with particular focus on innovative treatment approaches and metastatic disease management.
Investigation of targeted therapies and combination treatments for improved patient outcomes.
Clinical investigations focusing on obesity and type 2 diabetes, testing new therapeutic approaches for weight management and metabolic control.
Evaluation of novel medications combined with lifestyle interventions for optimal patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
